Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Feminic is a women's health product line developed by Laboratoire CCD (also known as Laboratoire de la Femme), a French pharmaceutical company specializing in gynecology and reproductive health. While the Feminic brand is most widely recognized for its range of intimate hygiene cleansing gels (such as Feminic 7 and Feminic 8, which feature *Calendula officinalis* extract for its soothing and anti-inflammatory properties), it is also categorized as a dietary supplement and consumer health product within the company's portfolio. In its oral formulation, Feminic is intended to support women's physiological balance and intimate well-being, often utilizing botanical extracts or probiotics to maintain healthy vaginal flora. As a consumer health product, it is marketed for the maintenance of health and does not undergo the traditional clinical trial phases required for prescription pharmaceuticals.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Feminic.